In agreement with previous findings from different experimental models, we found that proliferation of breast cancer and glioblastoma cells is coupled with the induction of cyclin D1, an activator of kinases driving progression through the G1 phase of the cell cycle, and with downregulation of p27, a negative regulator of the cell cycle. Here, CDKN1B is linked to breast cancer.